{"id":13,"date":"2026-07-01T08:09:19","date_gmt":"2026-07-01T08:09:19","guid":{"rendered":"https:\/\/cellbiology-dev.i-med.ac.at\/?page_id=13"},"modified":"2026-07-20T09:03:17","modified_gmt":"2026-07-20T09:03:17","slug":"institute-of-cell-biology","status":"publish","type":"page","link":"https:\/\/cellbiology-dev.i-med.ac.at\/index.php\/institute-of-cell-biology\/","title":{"rendered":"The Huber Laboratory"},"content":{"rendered":"
\n
\n
\n
\n\n
\"\"<\/picture><\/div>
<\/div><\/div>
\"\"<\/picture><\/div>
<\/div><\/div>
\"\"<\/picture><\/div>
<\/div><\/div>
\"\"<\/picture><\/div>
<\/div><\/div>
\"\"<\/picture><\/div>
<\/div><\/div><\/div>
\n <\/svg>
Startseite_Gebaude-2-scaled<\/div>
<\/div><\/div><\/div>
Labor-scaled<\/div>
<\/div><\/div><\/div>
entry-pics1<\/div>
<\/div><\/div><\/div>
entry-pics2<\/div>
<\/div><\/div><\/div>
cropped-Bild_home_Zelle-e1633955489502-1<\/div>
<\/div><\/div><\/div> <\/div>\n\n <\/div>\n <\/div>\n <\/div>\n
\"previous<\/div><\/div>
\"next<\/div><\/div><\/div><\/div><\/ss3-loader><\/div><\/div>
<\/div><\/div><\/ss3-force-full-width><\/div>\n\n\n

The Huber Laboratory: Lysosomal mTOR
Signalling \u2013 The Crossroads Between Signal Transduction and Endosomal Biogenesis<\/h1>\n\n\n\n

Our story begins in 2003 when we transformed our understanding of cellular signalling by identifying the LAMTOR\/Ragulator complex and showing how the p14-MP1 scaffold anchors MAPK signalling to endosomes, a crucial step in regulating cell growth and survival (Teis et al., Dev Cell 2003). In 2007, we linked this complex to human disease, identifying p14 deficiency as the cause of a devastating primary immunodeficiency (Bohn et al, Nat Med 2007). This was the first indication that LAMTOR was more than a mere signalling hub \u2013 it is a lifeline. The plot thickened in 2015 when, in collaboration with Giulio Superti-Furga, we discovered SLC38A9, the long-sought amino-acid sensor that allows mTORC1 to \u2018taste\u2019 nutrients in lysosomes (Rebsamen et al, Nature 2015). Suddenly the pieces fell into place \u2013 LAMTOR was not only a scaffold, it was the control centre of metabolic decision-making. The structural revolution enabled us in 2017 to capture the first crystal structure of LAMTOR\/Ragulator with Rag GTPases, revealing how this molecular machine aligns mTORC1 signalling on lysosomes (Araujo et al., Science 2017). In the same year, we showed that LAMTOR also controls lysosomal positioning, acting as a brake on endosomal motility (Filipek et al., JCB 2017). The story took an exciting turn in 2020, when \u2013 together with Jim Hurley and Andrea Ballabio \u2013 we linked LAMTOR dysfunction to the Birt-Hogg-Dub\u00e9 syndrome, showing how faulty mTORC1 regulation drives this rare disease (Napolitano et al., Nature 2020). Finally, in 2023, we unveiled the megacomplex \u2013 a gigantic assembly of mTORC1, TFEB, Ragulator and Rags \u2013 painting a complete picture of how lysosomes orchestrate cellular metabolism (Cui et al., Nature 2023). From cancer to immune disorders, the LAMTOR complex is at the heart of disease and we are gradually unlocking its secrets, one discovery at a time.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Publications<\/h2>\n\n\n\n